Titan Pharmaceuticals, Inc. Public Float
Titan Pharmaceuticals, Inc. had Public Float of $3.70 million as of 2024-06-30, per its 10-K filed 2025-03-20.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2025-03-20
- 2024-06-30: Entity Public Float $3.70M.
- 2022-06-30: Entity Public Float $7.30M; Entity Public Float as first filed $8.10M.
- 2021-06-30: Entity Public Float $25.60M.
- 2020-06-30: Entity Public Float $29.70M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2024-06-30 | $3.70M 10-K · filed 2025-03-20 | |
| 2022-06-30 | $7.30M 10-K · filed 2024-04-01 | $8.10M 10-K · filed 2023-03-31 |
| 2021-06-30 | $25.60M 10-K · filed 2022-03-25 | |
| 2020-06-30 | $29.70M 10-K · filed 2021-03-31 | |
| 2019-06-28 | $17.30M 10-K · filed 2020-03-30 | |
| 2018-06-29 | $22.60M 10-K/A · filed 2019-04-02 | |
| 2017-06-30 | $39.40M 10-K · filed 2018-04-02 | |
| 2016-06-30 | $113.10M 10-K · filed 2017-03-16 | |
| 2015-06-30 | $86.40M 10-K · filed 2016-03-15 | |
| 2014-06-30 | $60.70M 10-K · filed 2015-03-31 | |
| 2013-06-30 | $37.10M 10-K · filed 2014-03-31 | |
| 2012-06-30 | $45.20M 10-K · filed 2013-03-18 | |
| 2011-06-30 | $105.50M 10-K · filed 2012-03-15 |